Is IDEX Corporation profitable in 2026?

Yes. IDEX reported Q1 2026 revenue of $886.9 million, up 8.9% YoY, with adjusted EPS of $2.00 beating the $1.78 consensus, and it raised full-year 2026 EPS guidance to $8.35-$8.55 as of April 30, 2026.

Could AI replace what IDEX Corporation makes?

No. IDEX sells physical hardware, pumps, valves, fluidics, optics, and rescue tools locked into customer qualification cycles in pharma, semiconductor, and aerospace. AI infrastructure buildout is instead fueling demand, with HST segment organic orders up 34% in Q4 2025 from data-center and semiconductor customers.

Who are IDEX Corporation's biggest competitors?

IDEX faces fragmented, niche-by-niche rivalry rather than one dominant challenger: Pentair and Xylem in water/wastewater pumps, Danaher and Thermo Fisher in life-sciences fluidics, and Parker Hannifin in sealing and fluid-handling components, per competitive-landscape analysis published March 19, 2026.

Is IDEX Corporation laying off employees?

No major layoffs are evident. Headcount was roughly 8,700-9,000 as of early 2026 per WSJ data, while third-party workforce tracker Revelio Labs counted 8,322 employees worldwide as of December 2025, essentially flat versus 8,337 in 2024.

Is IDEX Corporation a safe company to join in 2026?

IDEX is an S&P 500 industrial with 127 consecutive quarterly dividends declared as of June 2026 (raised to $0.73/share) and $248 million in 2025 share buybacks, though headcount has been flat to slightly declining since 2023 despite revenue growth.

Is IDEX stock a buy in July 2026?

Analysts rate IDEX (NYSE: IEX) a 'Moderate Buy' as of July 23, 2026, with 6 buy and 3 hold ratings from nine firms and an average 12-month price target of $244; market cap was approximately $16.4-16.5 billion at that date.

Manufacturing companies · United States

IDEX Corporation

idexcorp.com ↗

Maker of niche pumps, valves, and fluidics parts used in pharma, semiconductor, and data-center gear.

Hard to displace

Assessed 24 July 2026 · Evidence as of 24 July 2026

Strong structural protection; the business model survives ai pressure.

On the recordSince 24 July 2026 · Checkable from July 29, 2026 · Every call on the record Checkpoint: Q2 2026 earnings call, test of continued beat-and-raise streak and HST order trends

The call

IDEX's growth now leans heavily on AI-driven data-center spending, so its near-term fortune rises or falls with that same boom.

IDEX is a large industrial company that manufactures small, specialized components like pumps, valves, and optical parts used in pharmaceuticals, semiconductors, aerospace, and water systems. It is hard to replace because customers go through lengthy approval processes to qualify IDEX parts into their production lines, and switching to a competitor would require re-doing those expensive certifications, so IDEX gets steady repeat business for years. The main risk is that data-center and AI-related sales have become nearly 40% of revenue, so if technology companies slow their spending on new computing infrastructure, IDEX's growth could stall.

Why

AI pressure: None apparent. AI infrastructure buildout is feeding IDEX, not eating it: data-center demand drives its fastest-growing segment. Could AI do the core job? Unlikely.

Bigger players: None apparent. Danaher and Fortive run the same small-parts playbook but haven't targeted IDEX's specific qualified customer niches. Could a giant copy it? No, they are blocked.

What protects it. Customers must requalify any replacement part through years of regulatory and process testing, so swapping suppliers costs more than it saves.

What would change this call

IDEX Q2 2026 earnings report on July 29, 2026. Shows whether the beat-and-raise streak and HST growth continue.
AMD, Nvidia, or hyperscaler capex guidance cuts in 2026. Would signal AI data-center spending slowdown threatening IDEX's HST segment.
Any writedown disclosure tied to the Mott Corporation acquisition. Would show overpaying or failed integration in IDEX's data-center bet.

Key numbers

FY2025 revenue $3.46B, up 5.77% YoY (2025-12-31)
Q1 2026 orders up 13% YoY to $988.3M (2026-03-31)
127 consecutive quarterly dividends paid (2026-06-30)

Named risks

HST segment concentration in AI/data-center capex; nearly half of backlog growth tied to data centers as of Q4 2025. Severity: high
Soft demand persists in FMT and FSDP segments (chemicals, agriculture, fire budgets) while growth relies on HST. Severity: medium
Integration risk from active bolt-on M&A pipeline including Feb 2026 filtration acquisition. Severity: medium
Tariff and global trade policy impacts flagged in IDEX's own forward-looking guidance risk disclosures. Severity: medium
New CFO Sean Gillen (effective Jan 5, 2026) represents a leadership transition execution risk. Severity: low

Rivals, as read in July 2026

Rival	Direction	Evidence
Pentair and Xylem	contesting	Water/wastewater pump rivalry pressuring IDEX's municipal water platform, noted 2026-03-19
Danaher	contesting	Sets competitive bar in life-sciences/HST fluidics while also acting as an OEM customer, per 2026-07-13 analysis
Parker Hannifin	contesting	Overlaps with IDEX in sealing devices and fluid-handling components, per 2025-10-17 competitor review
Fortive	contesting	Overlaps in sensing/instrumentation; flagged as potential entrant into IDEX's qualified niches

Questions people ask

Is IDEX Corporation profitable in 2026?: Yes. IDEX reported Q1 2026 revenue of $886.9 million, up 8.9% YoY, with adjusted EPS of $2.00 beating the $1.78 consensus, and it raised full-year 2026 EPS guidance to $8.35-$8.55 as of April 30, 2026.
Could AI replace what IDEX Corporation makes?: No. IDEX sells physical hardware, pumps, valves, fluidics, optics, and rescue tools locked into customer qualification cycles in pharma, semiconductor, and aerospace. AI infrastructure buildout is instead fueling demand, with HST segment organic orders up 34% in Q4 2025 from data-center and semiconductor customers.
Who are IDEX Corporation's biggest competitors?: IDEX faces fragmented, niche-by-niche rivalry rather than one dominant challenger: Pentair and Xylem in water/wastewater pumps, Danaher and Thermo Fisher in life-sciences fluidics, and Parker Hannifin in sealing and fluid-handling components, per competitive-landscape analysis published March 19, 2026.
Is IDEX Corporation laying off employees?: No major layoffs are evident. Headcount was roughly 8,700-9,000 as of early 2026 per WSJ data, while third-party workforce tracker Revelio Labs counted 8,322 employees worldwide as of December 2025, essentially flat versus 8,337 in 2024.
Is IDEX Corporation a safe company to join in 2026?: IDEX is an S&P 500 industrial with 127 consecutive quarterly dividends declared as of June 2026 (raised to $0.73/share) and $248 million in 2025 share buybacks, though headcount has been flat to slightly declining since 2023 despite revenue growth.
Is IDEX stock a buy in July 2026?: Analysts rate IDEX (NYSE: IEX) a 'Moderate Buy' as of July 23, 2026, with 6 buy and 3 hold ratings from nine firms and an average 12-month price target of $244; market cap was approximately $16.4-16.5 billion at that date.

Timeline

2026-07-23Market cap ~$16.4-16.5B; analysts rate IDEX Moderate Buy with $244 average target
2026-06-29127th consecutive quarterly dividend declared, raised to $0.73/share
2026-04-30Q1 2026 EPS $2.00 beats estimates; FY2026 EPS guidance raised to $8.35-$8.55
2026-02-04FY2025 results reported: revenue ~$3.46B, up 5.77% YoY; Q4 sales record $899.1M
2026-02-03Announced acquisition of flow-control and precision microporous filtration company
2026-01-05Sean M. Gillen becomes SVP and CFO
2025-07-31Micro-LAM, Inc. optics acquisition closed into HST unit
2024-12-31Mott Corporation acquisition closed, valued near $1 billion, IDEX's largest deal to date

Revision history

24 July 2026

First assessed. Hard to displace. The text above is fixed as of this date and is not edited afterwards.

In the same band

BHP Group Energy Transfer EOG Resources